Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alina Brandes

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
International Journal of Technology Assessment in Health Care|March 16, 2016
USING CLAIMS DATA FOR EVIDENCE GENERATION IN MANAGED ENTRY AGREEMENTSAlina Brandes, Larissa Schwarzkopf, Wolf H Rogowski
BMC Health Services Research|October 29, 2015
Early decision-analytic modeling - a case study on vascular closure devicesAlina Brandes, Moritz F Sinner, Stefan Kääb, et al.
BMC Health Services Research|November 20, 2016
Costs of conservative management of early-stage prostate cancer compared to radical prostatectomy-a claims data analysisAlina Brandes, Florian Koerber, Larissa Schwarzkopf, et al.
Zeitschrift Fur Gastroenterologie|March 16, 2019
Perianal fistulas in adult patients with Crohn's disease in Germany - a retrospective cross-sectional analysis of claims data from German sickness fundsElena Georgiadou, Lena Fanter, Alina Brandes, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 5, 2017
Manual Compression versus Vascular Closing Device for Closing Access Puncture Site in Femoral Left-Heart Catheterization and Percutaneous Coronary Interventions: A Retrospective Cross-Sectional Comparison of Costs and Effects in Inpatient CareJulia Walter, Matthias Vogl, Martin Holderried, et al.
Zeitschrift Fur Gastroenterologie|July 10, 2019
Real-world biologic treatment and associated cost in patients with inflammatory bowel diseaseAlina Brandes, Antje Groth, Fraence Gottschalk, et al.
Digestion|October 23, 2019
Persistence with Biologic Treatment in Patients with Inflammatory Bowel Disease: A German Claims Data AnalysisAntje Mevius, Alina Brandes, Fränce Hardtstock, et al.
BMC Gastroenterology|July 10, 2020
Real-world clinical effectiveness and safety of vedolizumab and anti-tumor necrosis factor alpha treatment in ulcerative colitis and Crohn's disease patients: a German retrospective chart reviewUlf Helwig, Michael Mross, Stefan Schubert, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
International Journal of Technology Assessment in Health Care|March 16, 2016
USING CLAIMS DATA FOR EVIDENCE GENERATION IN MANAGED ENTRY AGREEMENTSAlina Brandes, Larissa Schwarzkopf, Wolf H Rogowski
BMC Health Services Research|October 29, 2015
Early decision-analytic modeling - a case study on vascular closure devicesAlina Brandes, Moritz F Sinner, Stefan Kääb, et al.
BMC Health Services Research|November 20, 2016
Costs of conservative management of early-stage prostate cancer compared to radical prostatectomy-a claims data analysisAlina Brandes, Florian Koerber, Larissa Schwarzkopf, et al.
Zeitschrift Fur Gastroenterologie|March 16, 2019
Perianal fistulas in adult patients with Crohn's disease in Germany - a retrospective cross-sectional analysis of claims data from German sickness fundsElena Georgiadou, Lena Fanter, Alina Brandes, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 5, 2017
Manual Compression versus Vascular Closing Device for Closing Access Puncture Site in Femoral Left-Heart Catheterization and Percutaneous Coronary Interventions: A Retrospective Cross-Sectional Comparison of Costs and Effects in Inpatient CareJulia Walter, Matthias Vogl, Martin Holderried, et al.
Zeitschrift Fur Gastroenterologie|July 10, 2019
Real-world biologic treatment and associated cost in patients with inflammatory bowel diseaseAlina Brandes, Antje Groth, Fraence Gottschalk, et al.
Digestion|October 23, 2019
Persistence with Biologic Treatment in Patients with Inflammatory Bowel Disease: A German Claims Data AnalysisAntje Mevius, Alina Brandes, Fränce Hardtstock, et al.
BMC Gastroenterology|July 10, 2020
Real-world clinical effectiveness and safety of vedolizumab and anti-tumor necrosis factor alpha treatment in ulcerative colitis and Crohn's disease patients: a German retrospective chart reviewUlf Helwig, Michael Mross, Stefan Schubert, et al.
Pageof 1